Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Journal of Virology
|
October 17, 2006
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice
Nadine De Albuquerque, Ehtesham Baig, Xuezhong Ma, et al.
Drug Safety
|
April 19, 2023
Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines
Christine Stabell Benn, Nelly Amenyogbe, Anders Björkman, et al.
Blood
|
December 28, 2018
Identification and targeting of novel CDK9 complexes in acute myeloid leukemia
Elspeth M Beauchamp, Sameem M Abedin, Sara G Radecki, et al.
JAMA
|
December 25, 2003
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study
Mona R Loutfy, Lawrence M Blatt, Katharine A Siminovitch, et al.
Oncogene
|
April 13, 2021
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma
Mariafausta Fischietti, Frank Eckerdt, Gavin T Blyth, et al.
Nature Communications
|
April 2, 2022
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms
Diana Saleiro, Jeremy Q Wen, Ewa M Kosciuczuk, et al.
Antiviral Therapy
|
May 4, 2005
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids
Sarah E Ward, Mona R Loutfy, Lawrence M Blatt, et al.
Cell Reports
|
April 21, 2015
Central role of ULK1 in type I interferon signaling
Diana Saleiro, Swarna Mehrotra, Barbara Kroczynska, et al.
Eclinicalmedicine
|
August 4, 2023
Interferon β-1a ring prophylaxis to reduce household transmission of SARS-CoV-2: a cluster randomised clinical trial
José A Castro-Rodriguez, Eleanor N Fish, Samuel T Montgomery, et al.
Molecular Cancer Therapeutics
|
December 21, 2025
Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignancies
Elspeth M Beauchamp, Atul Jain, Matt Clutter, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Journal of Virology
|
October 17, 2006
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice
Nadine De Albuquerque, Ehtesham Baig, Xuezhong Ma, et al.
Drug Safety
|
April 19, 2023
Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines
Christine Stabell Benn, Nelly Amenyogbe, Anders Björkman, et al.
Blood
|
December 28, 2018
Identification and targeting of novel CDK9 complexes in acute myeloid leukemia
Elspeth M Beauchamp, Sameem M Abedin, Sara G Radecki, et al.
JAMA
|
December 25, 2003
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study
Mona R Loutfy, Lawrence M Blatt, Katharine A Siminovitch, et al.
Oncogene
|
April 13, 2021
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma
Mariafausta Fischietti, Frank Eckerdt, Gavin T Blyth, et al.
Nature Communications
|
April 2, 2022
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms
Diana Saleiro, Jeremy Q Wen, Ewa M Kosciuczuk, et al.
Antiviral Therapy
|
May 4, 2005
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids
Sarah E Ward, Mona R Loutfy, Lawrence M Blatt, et al.
Cell Reports
|
April 21, 2015
Central role of ULK1 in type I interferon signaling
Diana Saleiro, Swarna Mehrotra, Barbara Kroczynska, et al.
Eclinicalmedicine
|
August 4, 2023
Interferon β-1a ring prophylaxis to reduce household transmission of SARS-CoV-2: a cluster randomised clinical trial
José A Castro-Rodriguez, Eleanor N Fish, Samuel T Montgomery, et al.
Molecular Cancer Therapeutics
|
December 21, 2025
Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignancies
Elspeth M Beauchamp, Atul Jain, Matt Clutter, et al.
Page
of 12